Check out the companies making headlines in midday trading. Fortinet — Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won’t hurt the company as much as some suspect. The firm’s $100 price target suggests 29% upside ahead. Bausch Health — The pharmaceutical stock fell 9% after one of its experimental treatments missed targets in a late-stage clinical trial. Bausch was working on a treatment for hepatic encephalopathy, a condition where toxins build up in the blood, hurting brain function, in patients with liver disease. Moderna — The biotech’s stock pulled back 6%, breaking a four-day win streak. The move follows CEO Stephane Bancel telling Bloomberg TV that the company doesn’t plan on investing in new late-stage vaccine trials due to U.S. opposition to immunizations. Intel — Shares fell 16% after Intel reported mixed fourth-quarter results and issued a weak forecast. Intel expects first-quarter revenue will be between $11.7 billion and $12.7 billion, with adjusted profit breaking even. Analysts surveyed by LSEG expected the chipmaker to earn 5 cents per share on $12.51 billion in revenue. Clorox — The maker of household cleaning products rose almost 3% after it agreed to acquire Gojo Industries , the manufacturer of Purell, for $2.25 billion. Excluding the impact of the purchase, Clorox reaffirmed its 2026 outlook. SLM — The education lending company also known as Sallie Mae popped nearly 3% after reporting fourth–quarter earnings of $1.12 per share, topping the FactSet consensus estimate of 94 cents a share. SLM also authorized a new $500 million share repurchase program. Nvidia — The chipmaker’s shares rose about 1.6% after CNBC reported that CEO Jensen Huang plans to visit China in the coming days ahead of the mid-February Lunar New Year. The report comes as questions over the U.S. chip giant’s ability to sell in the Chinese market swirl. Life360 – Shares rose about 28% after the location-sharing application reported that its monthly active user base grew 20% to 95.8 million users last year. The company also posted better-than-expected preliminary financial results for 2025. Capital One — The stock dropped more than 6%. The bank announced on Thursday that it agreed to acquire startup Brex for $5.15 billion , in a deal consisting of 50% cash and 50% stock. Separately, fourth quarter adjusted earnings came up short against analysts’ estimates, landing at $3.86 per share. The LSEG consensus called for $4.11 per share. Booz Allen Hamilton – The technology consulting and engineering stock rose more than 7% after it hiked its first-quarter earnings forecast. Booz Allen Hamilton expects adjusted earnings of between $5.95 and $6.15 per share, or higher than its previous guidance of $5.45 to $5.65 per share. The figure also tops the FactSet consensus estimate of $5.62 per share. CSX — Shares of the railway operator jumped almost 5%. CSX said its intermodal revenue for the fourth quarter came in at $562 million, topping the StreetAccount consensus estimate of $551.2 million. The company also said it expects to see full-year 2026 revenue to rise by low single digits. — CNBC’s Nick Wells and Pia Singh contributed reporting.
https://www.cnbc.com/2026/01/23/stocks-making-the-biggest-moves-midday-ftnt-mrna-intc-bhc.html
